arXiv (All)
open access
Detecting Brain Cancer Progression Through Signatures of Wearable Accelerometry Data
Glioblastoma and other high-grade gliomas (HGG) have a poor prognosis and are associated with progressive functional decline. The standard of care to assess progressive disease is contrast-enhanced MRI, which is expensive, claustrophobic, and performed only once every 2-3 months. Wearable accelerome
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Glioblastoma in adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.#450043
- Cognitive Rehabilitation of Glioma Patients#913042
- Reference frame for Adult Brainstem gliomas#1329358
- Expanded Access to Gallium Maltolate (GaM)#830920
- A Phase 1b Study of PTC596 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma and High Grade Glioma#890412
Record · ID 1488813
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive